Bristol Myers Correlations
| BMY Stock | MXN 1,222 16.45 1.36% |
The current 90-days correlation between Bristol Myers Squibb and Micron Technology is 0.26 (i.e., Modest diversification). The correlation of Bristol Myers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Bristol Myers Correlation With Market
Significant diversification
The correlation between Bristol Myers Squibb and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and DJI in the same portfolio, assuming nothing else is changed.
Bristol |
The ability to find closely correlated positions to Bristol Myers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol Myers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol Myers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.
Moving together with Bristol Stock
Moving against Bristol Stock
Related Correlations Analysis
| 0.68 | 0.65 | 0.7 | 0.56 | 0.83 | MU | ||
| 0.68 | 0.81 | 0.94 | 0.87 | 0.83 | SPORTS | ||
| 0.65 | 0.81 | 0.8 | 0.59 | 0.72 | X | ||
| 0.7 | 0.94 | 0.8 | 0.78 | 0.85 | CTSH | ||
| 0.56 | 0.87 | 0.59 | 0.78 | 0.66 | LUV | ||
| 0.83 | 0.83 | 0.72 | 0.85 | 0.66 | TSMN | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Bristol Stock performing well and Bristol Myers Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bristol Myers' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MU | 2.40 | 0.00 | 0.00 | 0.12 | 3.02 | 4.91 | 20.67 | |||
| SPORTS | 1.16 | 0.37 | 0.08 | (0.88) | 1.51 | 3.23 | 12.22 | |||
| X | 2.41 | 0.32 | 0.04 | (1.36) | 3.72 | 5.11 | 20.60 | |||
| CTSH | 0.14 | 0.06 | 0.00 | 2.63 | 0.00 | 0.00 | 4.32 | |||
| LUV | 1.25 | 0.35 | 0.07 | (1.53) | 1.50 | 2.92 | 14.05 | |||
| TSMN | 1.89 | 0.20 | 0.05 | 0.85 | 2.26 | 3.37 | 14.40 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bristol Myers without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Bristol Myers Corporate Management
Elected by the shareholders, the Bristol Myers' board of directors comprises two types of representatives: Bristol Myers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bristol. The board's role is to monitor Bristol Myers' management team and ensure that shareholders' interests are well served. Bristol Myers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bristol Myers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jitendra Tyagi | Head India | Profile | |
| Cari Gallman | VP Officer | Profile | |
| David Elkins | Ex CFO | Profile | |
| BCH BM | Ex Devel | Profile | |
| Giovanni MD | Chairman CEO | Profile | |
| Greg Meyers | Ex Officer | Profile |